Albert Einstein Colege of Medicine, Memorial Sloan Kettering and Immune-Onc deal

Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center granted Immune-Onc exclusive, global rights to develop and commercialize biotherapeutics to treat cancer. Einstein and ...